Peptide-based immunotherapeutic approaches to glioma: a review |
| |
Authors: | Yamanaka Ryuya Itoh Kyogo |
| |
Affiliation: | Kurume University School of Medicine, Research Center of Innovative Cancer Therapy, Asahimachi 67, Kurume, Fukuoka 830-0011, Japan. ryaman@med.kurume-u.ac.jp |
| |
Abstract: | Despite advances in surgery, radiation and chemotherapy, the prognosis of patients with malignant glioma is still very poor; therefore, the development of a novel therapeutic modality is essential. There are increasing reports demonstrating that systemic immunotherapy using dendritic cells or a peptide vaccine is capable of inducing an antiglioma response. Peptide-based immunotherapy strategies appear promising as an approach to successfully induce an antitumor immune response and prolong survival in patients with glioma without major side effects. Now, peptide-based immunotherapy could be a new treatment modality for patients with brain tumors. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|